BSE Live
Dec 24, 15:40Prev. Close
5593.95
Open Price
5575.15
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 24, 15:57Prev. Close
5597.00
Open Price
5570.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
| Key Financial Ratios of Alkem Laboratories (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 181.11 | 150.19 | 82.31 | 137.63 | 132.57 | |
| Diluted EPS (Rs.) | 181.11 | 150.19 | 82.31 | 137.63 | 132.57 | |
| Cash EPS (Rs.) | 215.24 | 176.56 | 110.18 | 165.98 | 158.29 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 1,002.50 | 896.23 | 789.21 | 740.05 | 632.20 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 1,002.50 | 896.23 | 789.21 | 740.05 | 632.20 | |
| Revenue from Operations/Share (Rs.) | 1,084.44 | 1,059.61 | 970.24 | 889.52 | 741.53 | |
| PBDIT/Share (Rs.) | 251.43 | 213.83 | 152.70 | 185.33 | 181.98 | |
| PBIT/Share (Rs.) | 221.56 | 188.79 | 126.73 | 159.90 | 159.01 | |
| PBT/Share (Rs.) | 211.38 | 169.23 | 109.14 | 154.27 | 154.09 | |
| Net Profit/Share (Rs.) | 185.36 | 151.52 | 84.22 | 140.55 | 135.32 | |
| NP After MI And SOA / Share (Rs.) | 181.14 | 150.21 | 82.32 | 137.65 | 132.58 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 23.18 | 20.18 | 15.73 | 20.83 | 24.54 | |
| PBIT Margin (%) | 20.43 | 17.81 | 13.06 | 17.97 | 21.44 | |
| PBT Margin (%) | 19.49 | 15.97 | 11.24 | 17.34 | 20.77 | |
| Net Profit Margin (%) | 17.09 | 14.29 | 8.67 | 15.80 | 18.24 | |
| NP After MI And SOA Margin (%) | 16.70 | 14.17 | 8.48 | 15.47 | 17.87 | |
| Return on Networth/Equity (%) | 18.06 | 17.41 | 10.88 | 19.05 | 21.48 | |
| Return on Capital Employed (%) | 19.29 | 19.49 | 15.07 | 20.63 | 24.01 | |
| Return on Assets (%) | 12.24 | 11.52 | 7.15 | 11.69 | 13.75 | |
| Total Debt/Equity (X) | 0.09 | 0.12 | 0.14 | 0.30 | 0.23 | |
| Asset Turnover Ratio (%) | 0.78 | 0.86 | 0.83 | 0.72 | 76.95 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 2.76 | 2.61 | 2.35 | 1.76 | 1.92 | |
| Quick Ratio (X) | 2.02 | 1.94 | 1.65 | 1.13 | 1.28 | |
| Inventory Turnover Ratio (X) | 4.64 | 1.25 | 1.09 | 1.33 | 3.83 | |
| Dividend Payout Ratio (NP) (%) | 23.18 | 29.96 | 53.45 | 0.00 | 21.12 | |
| Dividend Payout Ratio (CP) (%) | 19.90 | 25.68 | 40.63 | 0.00 | 18.00 | |
| Earnings Retention Ratio (%) | 76.82 | 70.04 | 46.55 | 0.00 | 78.88 | |
| Cash Earnings Retention Ratio (%) | 80.10 | 74.32 | 59.37 | 0.00 | 82.00 | |
| Coverage Ratios | ||||||
| Interest Coverage Ratios (%) | 24.70 | 22.74 | 17.00 | 42.31 | 32.26 | |
| Interest Coverage Ratios (Post Tax) (%) | 24.70 | 22.74 | 17.00 | 42.31 | 32.26 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 58,288.87 | 59,097.05 | 39,701.27 | 43,453.40 | 33,002.69 | |
| EV/Net Operating Revenue (X) | 4.50 | 4.67 | 3.42 | 4.09 | 3.72 | |
| EV/EBITDA (X) | 19.39 | 23.12 | 21.75 | 19.61 | 15.17 | |
| MarketCap/Net Operating Revenue (X) | 4.50 | 4.66 | 3.50 | 4.07 | 3.74 | |
| Retention Ratios (%) | 76.81 | 70.03 | 46.54 | 0.00 | 78.87 | |
| Price/BV (X) | 4.87 | 5.73 | 4.49 | 5.01 | 4.49 | |
| Price/Net Operating Revenue | 4.50 | 4.66 | 3.50 | 4.07 | 3.74 | |
| Earnings Yield | 0.04 | 0.03 | 0.02 | 0.04 | 0.05 |
04.12.2025
Alkem Lab Consolidated September 2025 Net Sales at Rs 4,000.99 crore, up 17.17% Y-o-Y
24.11.2025
Alkem Lab Standalone September 2025 Net Sales at Rs 2,542.03 crore, down 11.49% Y-o-Y
10.09.2025
Alkem Lab Standalone June 2025 Net Sales at Rs 2,372.17 crore, down 5.12% Y-o-Y
12.08.2025
Q1 Results impact: Alkem Labs, PN Gadgil shares rally up to 10% on strong earnings, Granules up 4%
12.07.2023
Alkem Laboratories Q1 PAT seen up 135.1% YoY to Rs 299.7 cr: Nirmal Bang
17.10.2018
Alkem Labs Q2 PAT may dip 30.2% YoY to Rs. 220 cr: HDFC Securities
20.04.2018
Alkem Labs Q4 PAT may dip 1.5% YoY to Rs. 130 cr: HDFC Securities
12.04.2018
Pharma Q4 earnings preview: Tough quarter; US pricing pressure, domestic sales recovery hold key